✦ LIBER ✦

Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension

✍ Scribed by David Langleben; Brian W. Christman; Robyn J Barst; Virgil C. Dias; Nazzareno Galiè; Timothy W. Higenbottam; Meinhard Kneussl; Larry Korducki; Robert Naeije; Axel Riedel; Gerald Simonneau; Andrew M. Hirsch; Stuart Rich; Ivan M. Robbins; Ronald Oudiz; Michael D. McGoon; David B. Badesch; Robert D. Levy; Sanjay Mehta; Werner Seeger; Markus Solèr

Book ID: 117842782
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 122 KB
Volume: 143
Category: Article
ISSN: 1097-6744
DOI: 10.1067/mhj.2002.121806

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EFFECTS OF THROMBOXANE SYNTHETASE INHIBI

EFFECTS OF THROMBOXANE SYNTHETASE INHIBITOR (UK 38,485) AND THROMBOXANE RECEPTOR ANTAGONIST (ICI 185,282) ON DIGOXIN-INDUCED ARRHYTHMIAS IN ANAESTHETIZED GUINEA-PIGS

✍ I. Kanzik; A. T. Demiryürek; H. Zengil; N. Abacioǧlu; H. Dörtlemez 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 563 KB

Acute hemodynamic response to the S2-ser

Acute hemodynamic response to the S2-serotonergic receptor antagonist, ketanserin, in patients with primary pulmonary hypertension

✍ McGoon, Michael D.; Vlietstra, Ronald E. 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 492 KB

The haemodynamic effects of GR 32191, a

The haemodynamic effects of GR 32191, a thromboxane A2 receptor antagonist, in patients with renal artery stenosis and hypertension.

✍ D Lyons; G Fowler; JC Petrie; J Webster 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

Effects of the dual endothelin receptor

Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary hypertension: a placebo-controlled study

✍ R. Channick; D.B. Badesch; V.F. Tapson; G. Simonneau; I. Robbins; A. Frost; S. R 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Effects of the dual endothelin-receptor

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study

✍ Richard N Channick; Gérald Simonneau; Olivier Sitbon; Ivan M Robbins; Adaani Fro 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 90 KB

Role and Effect of Phosphodiesterase-5 I

Role and Effect of Phosphodiesterase-5 Inhibitors and Endothelin Receptor Antagonists in the Treatment of Moderate Pulmonary Hypertension

✍ Thiago Jabuonski; Jeremy A. Mazurek; Ronald Zolty 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 82 KB